Search

everythinglearnresearchcommunity

for

Search:↓

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Less attractive male venture capitalists take more risks influenced by entrepreneurs' looks, while more attractive ones are generally risk-tolerant.

Public interest in finasteride's sexual side effects has significantly increased.

Changes in SHBG levels don't predict diabetes risk reduction.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.

Male pattern baldness doesn't significantly affect mental health or sexual well-being.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Older age and low testosterone increase the risk of kidney stones in men.

Persistent ED in Propecia users is not due to abnormal blood flow.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

The questionnaire is valid and reliable but needs more testing for future predictions.

A vaccine may prevent benign prostatic hyperplasia (BPH).

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Hidradenitis suppurativa negatively affects patients' sexual lives and relationships, highlighting the need for better support and communication about sexual health.

Finasteride may cause depression and suicidal thoughts, especially in young men.